Literature DB >> 8757989

Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry.

P Devaux1, B Loveland, D Christiansen, J Milland, D Gerlier.   

Abstract

Recombinant soluble forms of the ectodomains of measles virus haemagglutinin (sH) and of its receptor CD46 (sCD46) were obtained as a purified disulphide-bonded sH homodimer with an apparent molecular mass of 160 kDa and a purified sCD46 monomer with an apparent molecular mass of 60 kDa, without detectable contamination with moesin. Purified sH bound to purified and immobilized sCD46 and this binding was specifically inhibited by sCD46 in solution. sCD46 bound to wild-type H expressed on the cell surface and inhibited measles virus binding to CD46-expressing cells. Binding of sCD46 to cell surface H was increased about twofold when measles virus fusion protein was coexpressed with H. sH bound to wild-type cell surface CD46 and inhibited measles virus binding onto CD46-expressing cells. sCD46 also inhibited virus infection. Thus, the direct interaction between the ectodomains of H and CD46 is likely to be the primary event in measles virus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757989     DOI: 10.1099/0022-1317-77-7-1477

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Recombinant measles viruses efficiently entering cells through targeted receptors.

Authors:  U Schneider; F Bullough; S Vongpunsawad; S J Russell; R Cattaneo
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats.

Authors:  S Niewiesk; J Schneider-Schaulies; H Ohnimus; C Jassoy; S Schneider-Schaulies; L Diamond; J S Logan; V ter Meulen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies.

Authors:  C Mumenthaler; U Schneider; C J Buchholz; D Koller; W Braun; R Cattaneo
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

5.  Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo.

Authors:  D Christiansen; P Devaux; B Réveil; A Evlashev; B Horvat; J Lamy; C Rabourdin-Combe; J H Cohen; D Gerlier
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.

Authors:  Caroline I Sellin; Nathalie Davoust; Vanessa Guillaume; Dominique Baas; Marie-Françoise Belin; Robin Buckland; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level.

Authors:  C Escoffier; D Gerlier
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding.

Authors:  P Devaux; C J Buchholz; U Schneider; C Escoffier; R Cattaneo; D Gerlier
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Moesin is not a receptor for measles virus entry into mouse embryonic stem cells.

Authors:  Y Doi; M Kurita; M Matsumoto; T Kondo; T Noda; S Tsukita; S Tsukita; T Seya
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

10.  Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding.

Authors:  P Devaux; D Gerlier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.